Final results of a phase 2 trial of clofarabine and low-dose cytarabine alternating with decitabine in older patients with newly diagnosed acute myeloid leukemia-Reference-Cited by-同舟云学术

Final results of a phase 2 trial of clofarabine and low-dose cytarabine alternating with decitabine in older patients with newly diagnosed acute myeloid leukemia

Published:2015-03-25 Issue:14 Volume:121 Page:2375-2382
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Kadia Tapan M.¹,Faderl Stefan²,Ravandi Farhad¹,Jabbour Elias¹,Garcia-Manero Guillermo¹,Borthakur Gautam¹,Ferrajoli Alessandra¹,Konopleva Marina¹,Burger Jan¹,Huang Xuelin³,Wang Xuemei³,Pierce Sherry¹,Brandt Mark¹,Feliu Jennie¹,Cortes Jorge¹,Kantarjian Hagop¹

Affiliation:

1. Department of Leukemia; The University of Texas MD Anderson Cancer Center; Houston Texas

2. Division of Leukemia; John Theurer Cancer Center; Hackensack New Jersey

3. Department of Biostatistics; The University of Texas MD Anderson Cancer Center; Houston Texas

Funder

National Institutes of Health

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference21 articles.

1. Results of intensive chemotherapy in 998 patients age 65 years or older with acute myeloid leukemia or high-risk myelodysplastic syndrome: predictive prognostic models for outcome;Kantarjian;Cancer,2006